These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34371202)

  • 1. Can platelet activation result in increased plasma Aβ levels and contribute to the pathogenesis of Alzheimer's disease?
    Carbone MG; Pagni G; Tagliarini C; Imbimbo BP; Pomara N
    Ageing Res Rev; 2021 Nov; 71():101420. PubMed ID: 34371202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Amyloid promotes platelet activation and activated platelets act as bridge between risk factors and Alzheimer's disease.
    Li TR; Liu FQ
    Mech Ageing Dev; 2022 Oct; 207():111725. PubMed ID: 35995275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
    Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
    Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular miRNAs correlate with the clearance of Aβ through perivascular route in younger 3xTg-AD mice.
    Fu L; Jiang G; Weng H; Dick GM; Chang Y; Kassab GS
    Brain Pathol; 2020 Jan; 30(1):92-105. PubMed ID: 31206909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid precursor protein is required for in vitro platelet adhesion to amyloid peptides and potentiation of thrombus formation.
    Visconte C; Canino J; Guidetti GF; Zarà M; Seppi C; Abubaker AA; Pula G; Torti M; Canobbio I
    Cell Signal; 2018 Dec; 52():95-102. PubMed ID: 30172024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing of amyloid precursor protein as a biochemical link between atherosclerosis and Alzheimer's disease.
    Jans DM; Martinet W; Van De Parre TJ; Herman AG; Bult H; Kockx MM; De Meyer GR
    Cardiovasc Hematol Disord Drug Targets; 2006 Mar; 6(1):21-34. PubMed ID: 16724933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
    Zhang S; Zhi Y; Li F; Huang S; Gao H; Han Z; Ge X; Li D; Chen F; Kong X; Lei P
    J Neurol Sci; 2018 Apr; 387():6-15. PubMed ID: 29571873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer's disease.
    Jarre A; Gowert NS; Donner L; Münzer P; Klier M; Borst O; Schaller M; Lang F; Korth C; Elvers M
    Cell Signal; 2014 Sep; 26(9):2040-50. PubMed ID: 24928203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Amyloid-β on Platelet Mitochondrial Function and Platelet-Mediated Amyloid Aggregation in Alzheimer's Disease.
    Donner L; Feige T; Freiburg C; Toska LM; Reichert AS; Chatterjee M; Elvers M
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.
    Henderson BW; Gentry EG; Rush T; Troncoso JC; Thambisetty M; Montine TJ; Herskowitz JH
    J Neurochem; 2016 Aug; 138(4):525-31. PubMed ID: 27246255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
    Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
    Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unaltered plasma levels of beta-amyloid(1-40) and beta-amyloid(1-42) upon stimulation of human platelets.
    Olsson A; Vanmechelen E; Vanderstichele H; Davidsson P; Blennow K
    Dement Geriatr Cogn Disord; 2003; 16(2):93-7. PubMed ID: 12784033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
    Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ
    Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
    Behl T; Kaur I; Fratila O; Brata R; Bungau S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.